These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27143168)

  • 41. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
    Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
    Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preparation and evaluation of schisandrin B-loaded F127 modified lipid-polymer nanoparticles for inhibition of breast cancer lung metastasis].
    Fei Y; Jiang-Pei S; Hai-Zhen C; Jun-Yi S; Xing-Mei X; Zi-Fei J; Xiao-Yan GU; Ying L; Nian-Ping F
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5177-5183. PubMed ID: 33350233
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.
    de Bono JS; Oudard S; Ozguroglu M; Hansen S; Machiels JP; Kocak I; Gravis G; Bodrogi I; Mackenzie MJ; Shen L; Roessner M; Gupta S; Sartor AO;
    Lancet; 2010 Oct; 376(9747):1147-54. PubMed ID: 20888992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.
    Moody TW; Sun LC; Mantey SA; Pradhan T; Mackey LV; Gonzales N; Fuselier JA; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1265-72. PubMed ID: 16766720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
    Breeman WA; de Jong M; Erion JL; Bugaj JE; Srinivasan A; Bernard BF; Kwekkeboom DJ; Visser TJ; Krenning EP
    J Nucl Med; 2002 Dec; 43(12):1650-6. PubMed ID: 12468515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
    Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
    Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives.
    Fragogeorgi EA; Zikos C; Gourni E; Bouziotis P; Paravatou-Petsotas M; Loudos G; Mitsokapas N; Xanthopoulos S; Mavri-Vavayanni M; Livaniou E; Varvarigou AD; Archimandritis SC
    Bioconjug Chem; 2009 May; 20(5):856-67. PubMed ID: 19344122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nebulised lipid-polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells.
    Vencken S; Foged C; Ramsey JM; Sweeney L; Cryan SA; MacLoughlin RJ; Greene CM
    ERJ Open Res; 2019 Apr; 5(2):. PubMed ID: 30972350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sigma-2 receptor ligand anchored telmisartan loaded nanostructured lipid particles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in prostate cancer cells.
    Puri R; Kaur Bhatia R; Shankar Pandey R; Kumar Jain U; Katare OP; Madan J
    Drug Dev Ind Pharm; 2016 Dec; 42(12):2020-2030. PubMed ID: 27184705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel stem-loop RNA and drug-bearing DNA hybrid nanostructures specific to LNCaP prostate carcinoma.
    Shin SW; Song WC; Kim AR; Cho SW; Kim DI; Um SH
    Biomater Sci; 2014 Jan; 2(1):76-83. PubMed ID: 32481809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular engineering of antibodies for site-specific conjugation to lipid polydopamine hybrid nanoparticles.
    Yang H; Le QV; Shim G; Oh YK; Shin YK
    Acta Pharm Sin B; 2020 Nov; 10(11):2212-2226. PubMed ID: 33304787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tax advantages for LPNS.
    Battersby ME
    Bedside Nurse; 1971 Feb; 4(2):25-7. PubMed ID: 5204840
    [No Abstract]   [Full Text] [Related]  

  • 54. Topical Drug Delivery of Concentrated Cabazitaxel in an α-Tocopherol and DMSO Solution.
    Sun B; Paraskevopoulos G; Min J; Rossdeutcher R; Ghosh S; Quinn B; Lin MH; Sarkar D; Sukumaran D; Wang Y; Vávrová K; Lovell JF; Zhang Y
    Adv Sci (Weinh); 2023 Oct; 10(29):e2302658. PubMed ID: 37555802
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual-Drug Nanosystem: Etoposide Prodrug and Cisplatin Coloaded Nanostructured Lipid Carriers for Lung Cancer Therapy.
    Du M; Yin J
    Drug Des Devel Ther; 2022; 16():4139-4149. PubMed ID: 36506793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined and targeted drugs delivery system for colorectal cancer treatment: Conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers.
    Liu Y; Zhang H; Cui H; Zhang F; Zhao L; Liu Y; Meng Q
    Drug Deliv; 2022 Dec; 29(1):342-350. PubMed ID: 35049388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanotechnology in the Treatment of Diabetic Complications: A Comprehensive Narrative Review.
    He Y; Al-Mureish A; Wu N
    J Diabetes Res; 2021; 2021():6612063. PubMed ID: 34007847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A surfactant-stripped cabazitaxel micelle formulation optimized with accelerated storage stability.
    Sun B; Jing H; Mabrouk MT; Zhang Y; Jin H; Lovell JF
    Pharm Dev Technol; 2020 Dec; 25(10):1281-1288. PubMed ID: 32892678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel.
    Zhang X; Wu Y; Zhang M; Mao J; Wu Y; Zhang Y; Yao J; Xu C; Guo W; Yu B
    Int J Nanomedicine; 2017; 12():8779-8799. PubMed ID: 29263668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles.
    Shao M; Yang W; Han G
    Int J Nanomedicine; 2017; 12():7121-7130. PubMed ID: 29026305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.